Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine for apathy and depressive symptoms in major neurocognitive disorder
RBR-7z47sgwPhase 2Recruiting
- Sponsor
- Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Dementia comparing Esketamine with Placebo (2 arms). Started Feb 2026; status: recruiting.
02
Drugs
esketamine
03
Conditions
Dementia
Beyond the preview
Go deeper on RBR-7z47sgw.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-7z47sgw.